Aykut Unsal, DO
Otolaryngology/Facial Plastic Surgery · Philadelphia, PANPI 1487095527
Payments from drug & device makers
What this record shows
Intersect ENT, Inc. accounts for 70.1% of it on its own, with 8 other manufacturers making up the rest. Reporting peaked in 2019 at $2,886 and has fallen 92.7% since, to $212 in 2024.
Across 37 payments — averaging $110.51 each. Meals, travel, consulting and speaking fees, gifts and royalties reported by drug and device makers.
- Intersect ENT, Inc.$3K
- Medtronic$328
- Stryker$260
- Optinose US, Inc.$216
- Sanofi$203
- AstraZeneca$100
- plus $114 from 3 others
What the payments were for
- Travel & lodging$2,02750%
- Food & beverage$2,06250%
Most of this is food and beverage — typically meals provided during product presentations at a clinic or hospital. Nationally that is the single largest category of reported payments by count.
General payments by program year
Who reported the general payments
Companies are grouped under their corporate parent — a single manufacturer often files under several CMS reporting entities. Research and ownership payments are counted separately and are not in this table.
| Company | Payments | Total |
|---|---|---|
| Intersect ENT, Inc. | 9 | $2,868 |
| Medtronic(2 entities) | 4 | $328 |
| Stryker | 3 | $260 |
| Optinose US, Inc. | 11 | $216 |
| Sanofi | 4 | $203 |
| AstraZeneca | 1 | $100 |
| Inspire Medical Systems, Inc. | 3 | $68 |
| Regeneron Healthcare Solutions, Inc. | 1 | $26 |
| GSK | 1 | $20 |
What the payments were tied to
Products named in the reported payments. Only payments of $100 or more are attributed here — the typical reported payment nationally is a meal worth about $16, and listing those product-by-product would be noise.
- SINUVA$2,590
- NUVENT$250
- SCOPIS ENT$136
- PROPEL$134
- DUPIXENT$133
How this compares
$4,089 in reported general payments places this provider in the 70th percentile of 21 otolaryngology/facial plastic surgery providers in Pennsylvania.
See all otolaryngology/facial plastic surgery providers in Pennsylvania →
Medicare billing
What this is not: this is the amount Original Medicare Part B allowed for services this provider billed in 2024. It is not their income. It excludes Medicare Advantage — now more than half of all Medicare enrollment — along with Medicaid and all commercial insurance, and it is gross practice revenue before staff, rent, supplies and malpractice premiums. CMS also suppresses any figure covering ten or fewer patients, so low-volume providers appear smaller than they are.
Most prescribed under Part D
| Drug | Claims | Cost to plans & patients |
|---|---|---|
| Omeprazole | 387 | $5,782 |
| Ciprofloxacin-DexamethasoneCiprofloxacin Hcl/Dexameth | 45 | $5,476 |
| Azelastine Hcl | 239 | $4,410 |
| Azelastine-FluticasoneAzelastine/Fluticasone | 48 | $4,323 |
| QnaslBeclomethasone Dipropionate | 13 | $3,889 |
| Mometasone Furoate | 43 | $3,628 |
| Fluticasone Propionate | 329 | $3,359 |
| Ipratropium Bromide | 104 | $2,730 |
| Famotidine | 222 | $2,568 |
| Esomeprazole Magnesium | 16 | $2,468 |
| Pantoprazole Sodium | 87 | $2,345 |
| Hydrocortisone-Acetic AcidHydrocortisone/Acetic Acid | 12 | $1,495 |
| Montelukast Sodium | 96 | $1,245 |
| Nortriptyline Hcl | 55 | $1,078 |
| Fluocinolone Acetonide Oil | 24 | $951 |
Paid to pharmacies, not to this prescriber.
Other otolaryngology/facial plastic surgery in Philadelphia
- Raphael GabayPhiladelphia$4K
- Harleen SethiPhiladelphia$3K
- Tasos AslanidisPhiladelphia$2K
- Joanna KamPhiladelphia$334
- Jason BloomBryn Mawr$718K
- Donald SessoNorristown$23K
- Sean CarrollErie$6K
- Melissa SchwartzElkins Park$5K
- Adam MariottiExton$5K
- Jeffrey BrigliaLanghorne$4K
Where these figures come from
- Payments: CMS Open Payments, program years 2019–2025 (publication P06302026_06032026).
- Billing: Medicare Physician & Other Practitioners, data year 2024. Original Medicare Part B only.
- Identity: NPPES NPI Registry, July 2026.